Latest News James Mazzo to Head Zeiss Meditec’s Newly Consolidated Ophthalmology Unit By Staff Friday, July 29, 2016 12:24 AM James Mazzo. JENA, Germany—James Mazzo will join Carl Zeiss Meditec as global president of ophthalmology with responsibility for the company’s new strategic business unit ophthalmology as well as Carl Zeiss Meditec's U.S. sales and service center.A prominent industry executive, Mazzo has over 35 years of ophthalmic experience. He most recently served as executive chair and CEO of Acufocus (see related article below).Prior to that, Mazzo spent over 20 years leading Allergan's North American and European eyecare organizations. He led the public spin-off of AMO as chairman/CEO, building that organization into a leading company in refractive, cataract and eyecare products. In 2009 Abbott Labs purchased AMO and Mazzo was selected as executive vice president to lead Abbott's global ophthalmology business. He left Abbott in 2013 to join AcuFocus and serve as executive chair of Neurotech.In a joint statement by executive and supervisory board of Carl Zeiss Meditec AG, Dr. Ludwin Monz, president and CEO, and Dr. Michael Kaschke, chairman of the supervisory board, commented, “We are excited to have Mr. Mazzo, one of the best experts in the ophthalmology industry join the Zeiss family. The reorganization and new leadership of the ophthalmology business will allow Carl Zeiss Meditec to extend the offering for ophthalmology and optometric customers globally. We see particular opportunities in extending the business in North America and parts of Asia.”